These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32840016)

  • 21. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK.
    Lee JS; Kang SU; Hwang HS; Pyun JH; Choung YH; Kim CH
    Toxicol Lett; 2010 Dec; 199(3):308-16. PubMed ID: 20883750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lovastatin protects against cisplatin-induced hearing loss in mice.
    Fernandez K; Spielbauer KK; Rusheen A; Wang L; Baker TG; Eyles S; Cunningham LL
    Hear Res; 2020 Apr; 389():107905. PubMed ID: 32062294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changing the time intervals between cisplatin cycles alter its ototoxic side effect.
    Bielefeld EC; Gonzalez A; DeBacker JR
    Hear Res; 2021 May; 404():108204. PubMed ID: 33618164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient Receptor Potential Channels and Auditory Functions.
    Ramkumar V; Sheth S; Dhukhwa A; Al Aameri R; Rybak L; Mukherjea D
    Antioxid Redox Signal; 2022 Jun; 36(16-18):1158-1170. PubMed ID: 34465184
    [No Abstract]   [Full Text] [Related]  

  • 26. Necroptosis and Apoptosis Contribute to Cisplatin and Aminoglycoside Ototoxicity.
    Ruhl D; Du TT; Wagner EL; Choi JH; Li S; Reed R; Kim K; Freeman M; Hashisaki G; Lukens JR; Shin JB
    J Neurosci; 2019 Apr; 39(15):2951-2964. PubMed ID: 30733218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activating transcription factor 6 contributes to cisplatin‑induced ototoxicity via regulating the unfolded proteins response.
    Liu YC; Bai X; Liao B; Chen XB; Li LH; Liu YH; Hu HJ; Xu K
    Biomed Pharmacother; 2024 Aug; 177():117025. PubMed ID: 38941893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are There Cochlear Dead Regions Involved in Hearing Loss after Cisplatin Ototoxicity?
    Schultz C; Pecora Liberman PH; Schmidt Goffi-Gomez MV
    Audiol Neurootol; 2019; 24(5):253-257. PubMed ID: 31661686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isotretinoin's action against cisplatin-induced ototoxicity in rats.
    Alan MA; Eryılmaz MA; Kaymaz F; Suzer A; Arıcıgil M
    Pak J Pharm Sci; 2018 Nov; 31(6 (Supplementary):2579-2584. PubMed ID: 30587464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect.
    Bielefeld EC; Tanaka C; Chen GD; Coling D; Li M; Henderson D; Fetoni AR
    Anticancer Drugs; 2013 Jan; 24(1):43-51. PubMed ID: 22828384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents.
    Schweitzer VG
    Laryngoscope; 1993 Apr; 103(4 Pt 2):1-52. PubMed ID: 8464301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Otoprotective Effects of Zingerone on Cisplatin-Induced Ototoxicity.
    Lee CH; Lee DH; Lee SM; Kim ASY
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The expression of copper transporters associated with the ototoxicity induced by platinum-based chemotherapeutic agents.
    Perde-Schrepler M; Fischer-Fodor E; Virag P; Brie I; Cenariu M; Pop C; Valcan A; Gurzau E; Maniu A
    Hear Res; 2020 Mar; 388():107893. PubMed ID: 32006874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of five agents in protecting the cochlea against the ototoxic effects of cisplatin in the hamster.
    Kaltenbach JA; Church MW; Blakley BW; McCaslin DL; Burgio DL
    Otolaryngol Head Neck Surg; 1997 Nov; 117(5):493-500. PubMed ID: 9374173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrophage depletion protects against cisplatin-induced ototoxicity and nephrotoxicity.
    Sung CYW; Hayase N; Yuen PST; Lee J; Fernandez K; Hu X; Cheng H; Star RA; Warchol ME; Cunningham LL
    Sci Adv; 2024 Jul; 10(30):eadk9878. PubMed ID: 39047106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose dependent protection by lipoic acid against cisplatin-induced ototoxicity in rats: antioxidant defense system.
    Rybak LP; Husain K; Whitworth C; Somani SM
    Toxicol Sci; 1999 Feb; 47(2):195-202. PubMed ID: 10220857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
    Huang X; Whitworth CA; Rybak LP
    Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Constant Light Dysregulates Cochlear Circadian Clock and Exacerbates Noise-Induced Hearing Loss.
    Yang CH; Hwang CF; Chuang JH; Lian WS; Wang FS; Huang EI; Yang MY
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Capsaicin Protects Against Cisplatin Ototoxicity by Changing the STAT3/STAT1 Ratio and Activating Cannabinoid (CB2) Receptors in the Cochlea.
    Bhatta P; Dhukhwa A; Sheehan K; Al Aameri RFH; Borse V; Ghosh S; Sheth S; Mamillapalli C; Rybak L; Ramkumar V; Mukherjea D
    Sci Rep; 2019 Mar; 9(1):4131. PubMed ID: 30858408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cisplatin ototoxicity and otoprotection with sodium salicylate.
    Hyppolito MA; de Oliveira JA; Rossato M
    Eur Arch Otorhinolaryngol; 2006 Sep; 263(9):798-803. PubMed ID: 16758221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.